Taxotere (docetaxel) is a drug that is manufactured by Sanofi-Aventis for use in treating a number of different types of cancer. In 2004, the Food and Drug Administration, FDA, approved Taxotere for the treatment of breast cancer. It has since been discovered that Taxotere can cause permanent hair loss.
Medical experts consider alopecia a non-life threatening disease in which the immune system mistakenly attacks the hair follicles, the structures from which hairs grow. This can lead to hair loss on the scalp and elsewhere.
In most cases, the hair loss may be limited to small round patches. But alopecia can progress to cause total loss of hair on the scalp or other parts of the body. This is apparently happening to a growing number of women who have taken Taxotere.
Taxotere is a chemotherapy drug made by Sanofi-Aventis and is used to treat breast cancer. The drug works by interfering with the growth and spread of cancer cells in the body. One can also choose Taxotere Hair Loss Attorneys for handling national Taxotere lawsuits if you have experienced permanent hairloss.
More women were open to the chemo drug Taxotere because prescribed treatments were only required once every three weeks, as opposed to once a week with other similar drugs.
Breast cancer patients are now filing Taxotere lawsuits, accusing Sanofi of hiding the chemo drug’s link to permanent hair loss from the American medical community.
The ingredients used in the drug may aggravate these conditions.
Other known side effects of Taxotere include the following:
- Light-headed feeling
- Fever and chills
- Swelling of the ankles and feet
- Redness, swelling, and irritation at the injection site